Atlas Trials

Hannah Choe, MD

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hannah Choe, MD

RecordFirmDate
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation (NCT07249346)Hannah Choe, MD2026-06-01
Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD (NCT04910152)Hannah Choe, MD2022-04-19

Track Hannah Choe, MD automatically

Every clearance here is in the API, with alerts when new ones post.